BioCentury
ARTICLE | Financial News

Celgene planning note deal

October 4, 2010 11:49 PM UTC

Celgene Corp. (NASDAQ:CELG) plans to sell senior unsecured notes in an offering underwritten by Citigroup; JPMorgan; and Morgan Stanley. Further terms were not disclosed. Celgene slipped $0.73 to $57....